Pharmaceuticals and Healthcare Reports Amyloidosis Market Size, Share, Growth, Trends, An

Amyloidosis Market Pipeline Analysis Report
2017
“The latest Pharmaceutical and Healthcare disease
pipeline guide Amyloidosis - Pipeline Review, H1
2017, provides an overview of the Amyloidosis
(Metabolic Disorders) pipeline landscape.”
Summary
The latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H1
2017, provides an overview of the Amyloidosis (Metabolic Disorders) pipeline landscape.
Abnormal accumulation of amyloid protein in the tissues results in a group of diseases known as
amyloidosis. It may affect the shape and functioning of the organ eventually leading to organ
failure. Predisposing factors are misfolding of abnormal protein called the light chain and its
subsequent deposition in the body. It may also occur as a result of dialysis. Symptoms include
fatigue, chest pain, swelling and breathing problems. Amyloidosis can be managed by transplant
and, medication such as diuretics and chemotherapy drugs.
Complete Report Available @ http://www.radiantinsights.com/research/amyloidosis-
pipeline-review-h1-2017
Report Highlights
The Pharmaceutical and Healthcare latest pipeline guide Amyloidosis - Pipeline Review, H1 2017,
provides comprehensive information on the therapeutics under development for Amyloidosis
(Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive
Follow Us: